Treatment of Chronic Hepatitis C in HIV-Infected Patients With PegIntron Pen and Rebetol According to German Law (67 Abs 6 AMG).
Phase of Trial: Phase IV
Latest Information Update: 05 Apr 2013
At a glance
- Drugs Peginterferon alfa-2b (Primary) ; Ribavirin (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- Sponsors Schering-Plough
- 10 Jun 2017 Biomarkers information updated
- 20 Jan 2012 Actual number of patients changed from 250 to 235 as reported by ClinicalTrials.gov.
- 20 Jan 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.